Staphylococcus Aureus Bacteremia
Infectious Disease·MeSH: Bacteremia
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| zevtera | Innoviva, Inc. (INVA) |
Unknown(1)
| Drug | Company |
|---|---|
| exebacase | CONTRAFECT Corp (CFRX) |
Phase 1/Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Staphylococcus Aureus Bacteremia?
BioSniper tracks 3 drugs in development for Staphylococcus Aureus Bacteremia across 3 companies.
How many clinical trials target Staphylococcus Aureus Bacteremia?
There are 2 clinical trials targeting Staphylococcus Aureus Bacteremia tracked by BioSniper.
Deep-dive into Staphylococcus Aureus Bacteremia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis